Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae440 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Ida Marie Boisen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, University Hospital Copenhagen, DK-2730 Herlev, Denmark. Hauptthemen laut MEDLINE: GTP-Binding Protein alpha Subunits, Hypercalcemia, Loss of Function Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Research Fund at Rigshospitalet, Beckett Foundation, Novo Nordisk Foundation.
Abstract (Originalsprache)
Context and Objectives To date, only 4 loss-of-function variants in the GNA11 gene encoding the G protein subunit α11 (Gα11) leading to familial hypocalciuric hypercalcemia (FHH) 2 have been characterized. Gα11 is involved in calcium-sensing receptor (CaSR) signaling, and loss-of-function variants in GNA11 lead to reduced agonist potency at CaSR and an FHH phenotype. Design and participants We have identified a family with a heterozygous GNA11 Thr347Ala variant and characterized its impact on calcium homeostasis in FHH2 patients and the signaling properties of CaSR through the Gα11-Thr347Ala variant in vitro. Main Outcome Measures The index patient and her family had clinical, biochemical, and genetic analyses performed. The expression levels of Gα11 and the cell-surface expression levels of CaSR in human embryonic kidney 293A Gq/11 knockout cells (ΔGq/11-HEK293A) cotransfected with CaSR and Gα11 [wild type (WT) or Thr347Ala] were determined, and the functional properties exhibited by calcium at CaSR were characterized in an inositol monophosphate (IP1) accumulation assay.
Results
Heterozygous carriers of the GNA11 Thr347Ala variant had mild asymptomatic hypercalcemia, hypocalciuria, and inappropriately high normal PTH levels considering their elevated serum calcium levels. Whereas the variant did not impact Gα11 expression or CaSR cell surface expression levels, calcium displayed a moderately but significantly lower agonist potency at CaSR/Gα11-Thr347Ala-transfected cells compared with CaSR/Gα11-WT-transfected cells in the IP1 accumulation assay (EC50 values of 5.67 mM and 4.38 mM, respectively).
Conclusion
This identification of a novel GNA11 variant causing FHH2 substantiates the important role of Gα11 for CaSR signaling and Ca2+ homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, University Hospital Copenhagen, DK-2730 Herlev, Denmark.
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, DK-2100 Copenhagen, Denmark.
- Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark.
- International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health, Copenhagen University Hospital-Rigshospitalet, DK-2100 Copenhagen, Denmark.
- Department of Clinical Medicine, University of Copenhagen, DK-2100 Copenhagen, Denmark.
ORCID-Profile: Ida Marie Boisen, Anders Juul, Hans Bräuner-Osborne, Anders A Jensen, Martin Blomberg Jensen
Förderung
- Research Fund at Rigshospitalet
- Beckett Foundation
- Novo Nordisk Foundation
- Candy Foundation
- Independent Research Fund Denmark
Zitieren
APA
Boisen, I. M., Du, W., Juul, A., Bräuner-Osborne, H., Jensen, A. A., & Blomberg Jensen, M. (2025). Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae440
Vancouver
Boisen IM, Du W, Juul A, Bräuner-Osborne H, Jensen AA, Blomberg Jensen M. Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae440
BibTeX
@article{Boisen2025,
author = {Boisen, Ida Marie and Du, Wei and Juul, Anders and Bräuner-Osborne, Hans and Jensen, Anders A and Blomberg Jensen, Martin},
title = {Loss-of-function Thr347Ala Variant in the G Protein Subunit-Α11 Causes Familial Hypocalciuric Hypercalcemia 2},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae440}
}
EUVIMED